It performed the analysis of the literature data on the peculiarities of the influence of type 2 diabetes mellitus on the endoprosthesis replacement of the steep joints in patients with diabetes mellitus outcomes. Reviewed the risk factors for complications of endoprosthetics, it is shown that in patients with diabetes mellitus operations on the hip joints are associated with higher rates of postoperative infection, the need for blood transfusion, the development of pneumonia and urinary tract infections, and increased hospital stays and higher rates nosocomial mortality. It was noted that in the course of making a decision on the performance of arthroplasty, surgical risk should be assessed for patients with diabetes, taking into account the possible complications of diabetes and the presence of other associated diseases. The basic principles of preoperative preparation, peri-and postoperative management of this cohort of patients are characterized.

Full Text

Restricted Access

About the authors

Leonid V. Ivanov

A.I. Evdokimov Moscow State Medical Stomatological University

the post-graduate student of the Department of Traumatology, orthopedics and medicine of catastrophes “A.I. Evdokimov Moscow State Medical Stomatological University”, 127473, Moscow, Russian Federation 127473, Moscow, Russian Federation

V. V Guriev

A.I. Evdokimov Moscow State Medical Stomatological University

127473, Moscow, Russian Federation

N. V Yarygin

A.I. Evdokimov Moscow State Medical Stomatological University

127473, Moscow, Russian Federation


  1. Hamilton D.F., Howie C.R., Burnett R. et al. Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J. 2015; 97B: 723-8.
  2. Dieterich J.D., Fields A.C., Moucha C.S. Short term outcomes of revision total knee arthroplasty. J. Arthroplast. 2014; 29: 2163-6.
  3. Liodakis E., Bergeron S.G., Zukor D.J. et al. Perioperative complications and length of stay after revision total hip and knee arthroplasties: an analysis of the NSQIP database. J. Arthroplasty. 2015; 30: 1868-71.
  4. Edwards P.K., Mears S.C., Stambough J.B. et al. Choices, Compromises, and Controversies in Total Knee and Total Hip Arthroplasty Modifiable Risk Factors: What You Need to Know. J. Arthroplasty. 2018; Feb 23. [Epub ahead of print]
  5. Прохоренко В.М., Азизов М.Ж., Шакиров Х.Х. Сопутствующие заболевания у пациентов с ревизионным эндопротезированием тазобедренного сустава. Acta Biomedica Scientifica. 2017; 2 (5): 136-40
  6. Berenbraum F. Diabetes-induced osteoarthritis: from new paradigm to a new phenotype. Ann. Rheum. Dis. 2011; 70(8): 1354-56.
  7. Jamsen E., Peltola M., Eskelinen A., Lehto M.U. Comorbid diseases as predictors of survival of primary total hip and knee replacements: a nationwide register-based study of 96 754 operations on patients with primary osteoarthritis. Ann. Rheum. Dis. 2013; 72: 1975-82.
  8. Chun Y.S., Lee S.H., Lee S.H. et al. Clinical Implication of Diabetes Mellitus in Primary Total Hip Arthroplasty. Hip Pelvis. 2014; 26: 136-42.
  9. Jain R.K., Shukla R., Singh P., Kumar R. Epidemiology and risk factors for surgical site infections in patients requiring orthopedic surgery. Eur. J. Orthop. Surg. Traumatol. 2015; 25: 251-4.
  10. Ekinci E.I., Kong A., Churilov L. et al. Using automated HbA1c testing to detect diabetes mellitus in orthopedic inpatients and its effect on outcomes. PLoS One. 2017; 12:e0168471.
  11. Pedersen A.B., Mehnert F., Johnsen S.P., Sorensen H.T. Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study. J. Bone Joint Surg. Br. 2010; 92: 929-34.
  12. Kunutsor S.K., Whitehouse M.R., Blom A.W., Beswick A.D. INFORM Team. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016; 11:e0150866.
  13. Fu A.Z., Iglay K., Qiu Y. et al. Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes. J. Diabetes Complications. 2014; 28: 805-10.
  14. Korbel L., Spencer J.D. Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States. J. Diabetes Complications. 2015; 29: 192-5.
  15. Schmolders J., Friedrich M.J., Michel R. et al. Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty. Int. Orthop. 2015; 39 (9): 1771-7.
  16. Koenig K., Huddleston J.I., Huddleston H. et al. Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. J. Arthroplasty. 2012; 27: 1402-7.



Abstract: 94

Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2019 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies